- Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surgi 991:78:676-8.
- Friedman S, Marion JF, Scheri E, Rubin PH, Present DH. Intravenous cyclosporin in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001;7:1-7.
- Carp JM, Onuma E, Das K, Gottlieb AB. Intravenous cyclosporin therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Cutis 1997;60:135-8.
- Sanders CJ, Hulsmans RF. Successful treatment of pyoderma gangrenosum with topical 5-aminosalicylic acid. Cutis 1993;51:262-4.
- Paolini O, Hebuterne X, Flory P, Charles F, Rambal P. Treatment of pyoderma gangrenosum with colchicine. Lancet 1995;345:1057-8.
- Alam M, Grossman ME, Schneiderman PI, Blume RS, Benvenisty AI. Surgical management of pyoderma gangrenosum [Case report and Review]. Dermatol Surg 2000;26:1063-6.
- Baert FJ, Rutgeeits PR. Anti-TNF strategies in Crohn's disease: mechanisms, clinical effects, indications. Int J Colored Dis 1999;14:47-51.
- Van der Schaar P, Wensveen C, Bavink JNB, van Hogezand R, et al. Treatment with anti-TNF Alpha (Remicade) for Pyoderma gangrenosum in Crohn's colitis [Case Report]. Gut 2000;32: Suppl 1,P.A245.
- Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn's disease with anti-tumor necrosis factor-alpha monoclonal antibody. Arch Dermatol 2001;137:930-3.
- Hong JJ, Merel NH, Hanauer SB. Treatment of Pyoderma gangrenosum complicating Crohn's disease with Infliximab. Gastroenterology 2001 ;120: Suppl 1,P. A-621.
- Fleisher MR, Rubin SD, Sasson M, Turner RL, et al. Remicade in the treatment of refractory extraintestinal manifestations of Crohn's disease. Gastroenterology 2001;120, Suppl 1, P. A-620.
- Botros N, Pickover L, Das K. Image of the month. Gastroenterology 2000; 118:654.
- Ardizzone S, Bollani S, Colombo E, Bianchi Porro G, et al. Infliximab for the treatment of Pyoderma gangrenosum in steroid dependent ulcerative colitis. Gut 2001 ;49 Suppl III, Abstr 3190.
Favorable Response to Infliximab Treatment in a Patient with Active Crohn Disease and Pyoderma Gangrenosum
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.